Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.01.2022 | Case report

Anti-CD19-CAR-transduced-T-cells

Cytokine release syndrome-associated coagulopathy: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ishihara T, et al. Suppressed Fibrinolytic Activity Demonstrated By Simultaneous Thrombin and Plasmin Generation Assay during Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy. Blood 138 (Suppl. 1): 4807-4809, 23 Nov 2021. Available from: URL: http://doi.org/10.1182/blood-2021-146311 [abstract] Ishihara T, et al. Suppressed Fibrinolytic Activity Demonstrated By Simultaneous Thrombin and Plasmin Generation Assay during Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy. Blood 138 (Suppl. 1): 4807-4809, 23 Nov 2021. Available from: URL: http://​doi.​org/​10.​1182/​blood-2021-146311 [abstract]
Metadaten
Titel
Anti-CD19-CAR-transduced-T-cells
Cytokine release syndrome-associated coagulopathy: 2 case reports
Publikationsdatum
01.01.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-08710-4

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Antineoplastics

Case report

Cotrimoxazole

Case report

Multiple drugs